Latest market price
307.15
+0.07+0.02%
SYKQT39Stryker Corporation·NYSE
307.15+0.02%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E31.83EPS (ttm)9.65Insider Own3.56%Shs Outstand383.57MPerf Week4.24%
Market Cap117.81BForward P/E18.41EPS next Y16.68Insider Trans-4.93%Shs Float348.14MPerf Month13.86%
Enterprise Value129.28BPEG2.79EPS next Q-Inst Own59.40%Short Float1.65%Perf Quarter-8.79%
Income3.73BP/S4.56EPS this Y10.26%Inst Trans0.00%Short Ratio2.19Perf Half Y-6.22%
Sales25.84BP/B4.91EPS next Y11.56%ROA7.78%Short Interest5.74MPerf YTD-12.61%
Book/sh62.54P/C33.89EPS next 5Y11.42%ROE16.36%52W High389.34 -21.11%Perf Year-20.91%
Cash/sh9.06P/FCF25.06EPS past 3/5Y10.83% 14.87%ROIC9.82%52W Low266.99 15.04%Perf 3Y13.68%
Dividend Est.3.52 (1.15%)EV/EBITDA19.32Sales past 3/5Y10.83% 11.84%Gross Margin65.17%Volatility2.85% 2.63%Perf 5Y15.33%
Dividend TTM3.52 (1.15%)EV/Sales5.00EPS Y/Y TTM24.36%Oper. Margin22.03%ATR (14)8.36Perf 10Y170.43%
Dividend Ex-DateSep 30, 2026Quick Ratio1.33Sales Y/Y TTM14.35%Profit Margin14.43%RSI (14)64.22Recom2.27
Dividend Gr. 3/5Y6.25% 7.62%Current Ratio2.16EPS Q/Q17.89%SMA207.40%Beta0.78Target Price365.89
Payout35.32%Debt/Eq0.73Sales Q/Q9.42%SMA503.84%Rel Volume0.74Prev Close307.08
Employees56,000LT Debt/Eq0.68EarningsOct 29SMA200-5.58%Avg Volume2.66MPrice307.15
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.5.78% 0.15%Net Debt/EBITDA1.73Volume1,984,556Change0.02%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-12-26ReiteratedBTIGBuy$358 → $316
Oct-06-26InitiatedBarclaysOverweight$394 → $375
Sep-30-26ReiteratedStifel NicolausBuy$360 → $330
Sep-18-26ReiteratedCanaccord GenuityBuy$400 → $385
Sep-09-26ReiteratedBMO CapitalOutperform$369 → $317
Sep-09-26ReiteratedWells FargoOverweight$286 → $348
Aug-13-26DowngradeWolfe ResearchOutperform → Peer Perform
Jul-31-26ReiteratedRaymond JamesOutperform$383 → $370
Jul-31-26ReiteratedWolfe Research$375
Jul-31-26ReiteratedRBC CapitalOutperform$435 → $420
Latest News· Times ET
Oct-23-26
Oct-22-26
Oct-21-26
Oct-19-26
Oct-15-26
Oct-14-26
Company

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Ownership
Total institutional ownership59.40%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue25,83725,11622,595——————
Cost of Goods Sold Incl. D&A9,0009,0518,050——————
Gross Profit16,83716,06514,545——————
Selling, General and Administrative Excl. Other8,7828,6517,503——————
Research and Development1,6581,5821,466——————
Other Operating Expense7069431,887——————
Operating Income5,6914,8893,689——————
Interest Expense827607396——————
Unusual Expense
—————————
Non-Operating Income (Expense)284232199——————
Net Income Before Taxes5,1484,5143,492——————
Income Taxes1,4191,268499——————
Consolidated Net Income3,7293,2462,993——————
Net Income From Continuing Operations3,7293,2462,993——————
Net Income3,7293,2462,993——————
EPS (Recurring)9.738.497.86——————
EPS (Basic, Before Extraordinaries)9.738.497.86——————
EPS (Diluted)9.658.407.76——————
EBITDA6,6926,3146,006——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio31.8341.8446.40——————
Price To Sales Ratio4.565.356.07——————
Gross Margin65.1763.9664.37——————
Operating Margin22.0319.4716.33——————
Net Margin14.4312.9213.25——————
Shares Outstanding384382381——————
Market Capitalization117,946134,262137,179——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$413.03$372.54$332.04$291.55$251.06● Close Price0.00M46.35M92.69M139.04M185.38MUSD Trades VolumeOctNovDec2026FebMarAprMayJunJulAugSepOct
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BRAINERD MARY KDirectorNov 22 '22Buy225.19184,054131Sep 02
BRAINERD MARY KDirectorJun 12 '20Buy185.653557102Sep 02
BRAINERD MARY KDirectorMay 12 '20Buy193.21366,95699Sep 02
BRAINERD MARY KDirectorSep 12 '19Buy221.03112,4310Sep 02
BRAINERD MARY KDirectorJun 26 '19Buy202.216312,73963Sep 02
Crotty Dylan BramGroup PresidentAug 21 '26Sale328.61441144,9156,102Aug 26
STRYKER RONDA EDirectorAug 19 '26Sale340.1050,00017,005,1652,251,375Aug 20
STRYKER RONDA EDirectorAug 18 '26Sale335.90300,000100,770,9632,301,375Aug 20
King DebraSee RemarksAug 18 '26Sale336.30826277,7876,210Aug 18
Fletcher Robert SVP, Chief Legal OfficerMay 28 '26Sale306.874,5441,394,41010,582May 29
STRYKER RONDA EDirectorMay 26 '26Sale312.23310,00096,792,6691,924,880May 28
Fink M KathrynVP, Chief HR OfficerMay 11 '26Sale283.698,7202,473,756177May 12
Fink M KathrynVP, Chief HR OfficerMay 08 '26Option Exercise167.9821,5823,625,38834,719May 12
Menon VijuGroup PresidentMar 21 '26Option Exercise0.00269022,100Mar 24
Stiles Spencer SPresident and COOMar 21 '26Option Exercise0.00430084,324Mar 24
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.